Kahn-Sagol-Maccabi Research and Innovation Institute, Maccabi Healthcare Services, Tel Aviv, Israel.
Kahn-Sagol-Maccabi Research and Innovation Institute, Maccabi Healthcare Services, Tel Aviv, Israel.
Reprod Toxicol. 2019 Oct;89:173-177. doi: 10.1016/j.reprotox.2019.07.083. Epub 2019 Jul 31.
To examine whether there is an association between the cumulative dose of folic acid (FA) purchased by mothers, and risk of autistic spectrum disorders (ASD) in their progeny.
We identified 2009 singletons who received an ASD diagnosis from a cohort of 480,526 children born in a large health organization in Israel from 2000 through 2013. ASD patients were individually matched to ASD-free children (n = 19,886). Median cumulative daily doses of supplemented FA during the 12-month period prior to the end of pregnancy (from dispensing records) were compared using conditional logistic regression models.
Children with ASD were more likely to be first-born, and birth-order was significantly associated with FA use. In multivariable analysis, there were no statistically significant differences in the cumulative dose of FA between the groups.
Birth order effects need to be accounted for in analyses aiming to decipher the associations between gestational FA use and developmental outcomes.
探讨母亲购买的叶酸(FA)累积剂量与后代自闭症谱系障碍(ASD)风险之间是否存在关联。
我们从 2000 年至 2013 年在以色列一个大型医疗机构出生的 480526 名儿童中确定了 2009 名接受 ASD 诊断的单胎。ASD 患者与无 ASD 儿童(n=19886)进行个体匹配。使用条件逻辑回归模型比较妊娠结束前 12 个月(从配药记录)中补充 FA 的累积日剂量中位数。
患有 ASD 的儿童更有可能是长子,并且出生顺序与 FA 使用显著相关。在多变量分析中,两组之间 FA 累积剂量没有统计学上的显著差异。
在旨在破译妊娠期 FA 使用与发育结果之间关联的分析中,需要考虑出生顺序的影响。